Inosine pranobex – a known drug with new indications in recurrent respiratory infections

Zbigniew Doniec

eISSN: 2450-4459
ISSN: 2450-3517

Lekarz POZ

Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors

Editorial System

Submit your Manuscript

3/2023
vol. 9

Send email

Copy url:

abstract:

Inosine pranobex – a known drug with new indications in recurrent respiratory infections

Zbigniew Doniec

¹

Klinika Pneumonologii, Instytut Gruźlicy i Chorób Płuc, Oddział Terenowy w Rabce-Zdroju

LEKARZ POZ 03/2023

Online publish date: 2023/08/31

View full text Get citation

Recurrent respiratory infections are a significant clinical problem and a diagnostic and therapeutic challenge, especially in children. Inosine pranobex is a drug with proven immunomodulatory and antiviral properties. The article is a review of in vitro, in vivo, and clinical trials showing the usefulness of the drug in supporting the treatment of recurrent upper respiratory tract infections, along with the practical algorithm of conduct for physicians.

keywords:

Inosine pranobex – a known drug with new indications in recurrent respiratory infections

Zbigniew Doniec 1

recurrent respiratory infections, inosine pranobex

Zbigniew Doniec

¹